PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

Don't forget an added reason to be excited about the upcoming trial.

In the upcoming trial CiaB's parental cell line that produces the enzyme to convert the ifosfamide will undergo further evaluation from the FDA because the CiaB therapy is a biologic, right? So, once the enzyme producing cell line is reevaluated and the therapy is proven....then guess what?

The FDA becomes satisfied with the parental cell line data, and we'll have our "choice" enzyme producing cell line, approved by the FDA, to engineer and convert the cannabidiol/prodrug in the CiaB/cannabinoid therapy.

Go PharmaCyte!